Waters Co. (NYSE:WAT) Shares Sold by Unigestion Holding SA

Unigestion Holding SA lessened its position in Waters Co. (NYSE:WATFree Report) by 85.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,085 shares of the medical instruments supplier’s stock after selling 28,840 shares during the period. Unigestion Holding SA’s holdings in Waters were worth $1,674,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of WAT. Exchange Traded Concepts LLC acquired a new stake in shares of Waters in the 4th quarter worth about $35,000. VisionPoint Advisory Group LLC increased its stake in Waters by 300.0% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock valued at $39,000 after buying an additional 108 shares during the period. Wetzel Investment Advisors Inc. acquired a new position in Waters during the 4th quarter valued at about $39,000. Turtle Creek Wealth Advisors LLC acquired a new position in Waters during the 4th quarter valued at about $41,000. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its stake in Waters by 186.3% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 146 shares of the medical instruments supplier’s stock valued at $48,000 after buying an additional 95 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on WAT shares. Barclays lowered their target price on shares of Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 8th. Robert W. Baird lowered their target price on shares of Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. Jefferies Financial Group assumed coverage on shares of Waters in a research report on Monday, June 3rd. They set a “hold” rating and a $320.00 price objective for the company. TD Cowen raised their price objective on shares of Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Finally, Evercore ISI raised their price objective on shares of Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research report on Thursday, April 4th. One equities research analyst has rated the stock with a sell rating and eleven have given a hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $307.20.

Read Our Latest Stock Analysis on WAT

Waters Price Performance

NYSE WAT opened at $301.47 on Tuesday. The company has a 50 day simple moving average of $326.71 and a 200-day simple moving average of $323.52. The company has a debt-to-equity ratio of 1.60, a current ratio of 1.94 and a quick ratio of 1.30. The firm has a market capitalization of $17.88 billion, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 4.81 and a beta of 0.97. Waters Co. has a 52-week low of $231.90 and a 52-week high of $367.21.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.10 by $0.11. The business had revenue of $636.80 million during the quarter, compared to analyst estimates of $635.57 million. Waters had a net margin of 20.75% and a return on equity of 66.59%. The firm’s revenue was down 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.49 earnings per share. Equities research analysts predict that Waters Co. will post 11.85 earnings per share for the current fiscal year.

Insider Activity at Waters

In related news, Director Christopher A. Kuebler sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the transaction, the director now owns 14,716 shares of the company’s stock, valued at $5,321,894.24. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Director Richard H. Fearon purchased 1,000 shares of the company’s stock in a transaction dated Tuesday, May 28th. The shares were bought at an average price of $332.90 per share, with a total value of $332,900.00. Following the completion of the transaction, the director now directly owns 1,653 shares in the company, valued at approximately $550,283.70. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Christopher A. Kuebler sold 4,000 shares of Waters stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the transaction, the director now directly owns 14,716 shares in the company, valued at approximately $5,321,894.24. The disclosure for this sale can be found here. Insiders own 0.82% of the company’s stock.

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.